On 8 January 2026, the Commission disclosed its findings to KD Pharma Canada Ltd and invited the company to provide comments. No comments were received.
Recital 7, Regulation (EU) 2026/702
In forcesince 23 Mar 2026
On 8 January 2026, the Commission disclosed its findings to KD Pharma Canada Ltd and invited the company to provide comments. No comments were received.